Current Clinical Trials
Department: Oncology
Diagnosis: Breast
Principal Investigator: Lynch MD, Cynthia A.
Sub-Investigator(s):
Sponsor: NSABP
Indentifier #: NCT01547741
Title: NSABP B49, A Phase III Clinical Trial Comparing the Combination of Docetaxel Plus Cyclophosphamide to Anthracycline-Based Chemotherapy Regimens for Women with Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
Department: Oncology
Diagnosis: Gastrointestinal - Colon-Rectal
Principal Investigator: Lowry MD, Philip
Sub-Investigator(s):
Sponsor: CALGB
Indentifier #: NCT01150045
Title: CALGB 80702, A Phase III Trial of 6 Versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients With Resected Stage III Colon Cancer
Department: Family Medicine
Diagnosis: Miscellaneous
Principal Investigator: Tran M.D., Vinh
Sub-Investigator(s):
Sponsor: Abbott
Indentifier #: NCT01626742
Title: A Randomized Double Blinded Controlled Trial of an Oral Nutritional Supplement Containing AN 777 in Older Hospitalized Patients
Department: Oncology
Diagnosis: Gastrointestinal - Liver
Principal Investigator: O'Brien M.D., Edward Thomas
Sub-Investigator(s):
Sponsor: CALGB
Indentifier #: NCT01015833
Title: CALGB 80802, Phase III Randomized Study of Sorafenib Plus Doxorubicin Versus Sorafenib In Patients with Advanced Hepatocellular Carcinoma (HCC)
Department: Gastroenterology
Diagnosis: Gastrointestinal - Ulcerative Colitis
Principal Investigator: Georgetson M.D., Michael
Sub-Investigator(s):
Sponsor: Pfizer
Indentifier #: NCT01458574
Title: A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,
PARALLEL-GROUP STUDY OF ORAL CP-690,550 AS A MAINTENANCE
THERAPY IN SUBJECTS WITH ULCERATIVE COLITIS